Evidence map›Paper›PMID 34459483›Full record

ArticleGlycobiology2021

Proteoglycan 4 (lubricin) is a highly sialylated glycoprotein associated with cardiac valve damage in animal models of infective endocarditis.

Kemal Solakyildirim, Yi Li, Arnold S Bayer, Paul M Sullam, Yan Q Xiong, Carlito B Lebrilla, Barbara A Bensing

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Glycobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06266741 (The Predictive Value of Lubricin in Patients With Infective Endocarditis), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06266741 unknown statusnot on this mapstarted 2024, after this paper: background citation

The Predictive Value of Lubricin in Patients With Infective Endocarditis

TypeobservationalSponsorAydin Adnan Menderes UniversityRan2024 to 2026Enrolled60ConditionsInfective EndocarditisArmsLubricin
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Kemal SolakyildirimDepartment of Chemistry, University of California, Davis, CA 95616, USA.
Yi LiDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Arnold S BayerDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Paul M SullamDepartment of Medicine, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, CA 94121, USA.
Yan Q XiongDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Carlito B LebrillaDepartment of Chemistry, University of California, Davis, CA 95616, USA.
Barbara A BensingDepartment of Medicine, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, CA 94121, USA.ORCID 0000-0002-6288-2323
San Francisco VA Medical Center · USUniversity of California, Los Angeles · USErzincan Binali Yıldırım University · TRUCLA Medical Center · USUniversity of California, Davis · US

Funding

Mechanisms for ligand binding by serine-rich adhesins of Gram-positive pathogensR01AI106987 · NIAID · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI IVERSON, T M, SULLAM, PAUL M. · 2014 to 2018
$3.4M
Mechanisms and Circumvention of Daptomycin Resistance in Streptococcus mitisR01AI130056 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI BAYER, ARNOLD S · 2018 to 2022
$2.4M
The role of purine biosynthesis and stringent response in persistent MRSA endovascular infectionsR01AI139244 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI XIONG, YAN Q. · 2019 to 2023
$2.2M
American Heart Association-American Stroke Association 17SDG33660424NIAID NIH HHS R01 AI106987NIAID NIH HHS R01 AI130056NIAID NIH HHS R01 AI139244NIH HHS R01AI139244
6 · The paper itself

Abstract

Streptococcus gordonii and Streptococcus sanguinis are primary colonizers of tooth surfaces and are generally associated with oral health, but can also cause infective endocarditis (IE). These species express "Siglec-like" adhesins that bind sialylated glycans on host glycoproteins, which can aid the formation of infected platelet-fibrin thrombi (vegetations) on cardiac valve surfaces. We previously determined that the ability of S. gordonii to bind sialyl T-antigen (sTa) increased pathogenicity, relative to recognition of sialylated core 2 O-glycan structures, in an animal model of IE. However, it is unclear when and where the sTa structure is displayed, and which sTa-modified host factors promote valve colonization. In this study, we identified sialylated glycoproteins in the aortic valve vegetations and plasma of rat and rabbit models of this disease. Glycoproteins that display sTa vs. core 2 O-glycan structures were identified by using recombinant forms of the streptococcal Siglec-like adhesins for lectin blotting and affinity capture, and the O-linked glycans were profiled by mass spectrometry. Proteoglycan 4 (PRG4), also known as lubricin, was a major carrier of sTa in the infected vegetations. Moreover, plasma PRG4 levels were significantly higher in animals with damaged or infected valves, as compared with healthy animals. The combined results demonstrate that, in addition to platelet GPIbα, PRG4 is a highly sialylated mucin-like glycoprotein found in aortic valve vegetations and may contribute to the persistence of oral streptococci in this protected endovascular niche. Moreover, plasma PRG4 could serve as a biomarker for endocardial injury and infection.

Indexed as

Disease Models, AnimalAnimalsEndocarditis, BacterialFemaleHeart ValvesHumansProteoglycansRabbitsRatsRats, Sprague-DawleyStreptococcus gordoniiProteoglycanscardiovascularITIH4O-linked glycansialic acidthrombus

Identifiers

PMID34459483
PMCPMC8684468
OpenAlexW3197215019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.